论文部分内容阅读
目的 :评价BACE与ABI治疗支气管肺癌的近期疗效。方法 :将 173例支气管肺癌分为A、B两组 ,A组 15 4例应用支气管动脉灌注药物治疗 ,B组 19例应用支气管动脉化学栓塞治疗。结果 :A、B两组总缓解率分别为 5 3 2 5 %和78 95 %两组比较差异有显著意义 (P <0 0 5 )。两组 1年生存率A(5 7 14 % )、B(73 6 8% )比较差异有显著性意义 (P <0 0 5 )。结论 :BACE治疗支气管肺癌的短期疗效优于BAI。
Objective: To evaluate the short-term efficacy of BACE and ABI in the treatment of bronchial carcinoma. Methods: A total of 173 patients with bronchogenic carcinoma were divided into A and B groups. A group of 154 patients were treated with bronchial artery infusion and B group with 19 bronchial artery chemoembolization. Results: The total remission rates of group A and group B were 53 52% and 78 95%, respectively. There was significant difference between the two groups (P <0.05). Two-year survival rates A (5714%), B (73.68%) were significantly different (P <0 05). Conclusion: The short-term curative effect of BACE on bronchogenic carcinoma is better than BAI.